UAE Cancer Congress

www.uaecancercongress.ae 1

www.uaecancercongress.ae

11 - 13 OCTOBER 2012InterContinental Festival City,Dubai, UAE

U EC NCERCONGRESS 2012

Stay Connected: /uaecc2012 I /uaecancercongress I /uaecancercongress

Congress Secretariat: MCI Middle East, United Arab Emirates, Tel: +971 4 311 6300, Fax: +971 4 311 6301, E-mail: [email protected]

Gold Sponsors

Supported by

Silver Sponsors Support Sponsors

Official News DistributorCongress Partner Media PartnersOfficial Journal

Platinum Sponsor

ONCOLOGY

Congress Bag Sponsor

ONCOLOGYONCOLOGYPutting progress into practice Eisai MENA

ure p r o g r a m

eart

THE CONGRESS IS ACCREDITED WITH

25 ESMO-MORA CAT 1 POINTS

Under the patronage of

H.H. Sheikh Hamdan Bin Rashid Al MaktoumDeputy Ruler of Dubai, Minister of Finance and President of Dubai Health Authority

18 CPD CREDIT POINTSAccredited byDubai Health Authority

www.uaecancercongress.ae2

His Highness Sheikh Khalifa Bin Zayed Al NahyanPresident of the U.A.E


His Highness Sheikh Mohammed Bin Rashid Al MaktoumVice President, Prime Minister and Ruler of Dubai


His Highness Sheikh Hamdan Bin Rashid Al MaktoumDeputy Ruler of Dubai, Minister of Finance, UAE

President of Dubai Health Authority


Welcome Message ............................................................. 06

Organising Committee ........................................................ 07-08

Scientific Committee ........................................................... 09-11

Venue & Exhibition Layout .................................................. 12-13

Programme at a Glance ........................................................14

Sceintific Program ............................................................... 16-24

Faculty Profile ................................................................... 26-74

Best Abstracts ................................................................... 76-83

Experience Dubai .............................................................. 86-89

Acknowledgement .............................................................. 90

Table of Contents


Welcome Message

First you start with an idea, a dream and then you place the foundation upon which to build that dream and then

continue to build and watch it grow into something above and beyond your expectation. This has been the journey

of the UAE Cancer Congress. We started of with a small congress in 2009 with the hope of promoting a multidis-

ciplinary approach to the management of individuals with cancer. Weve watched the congress not only grow but

develop into something that the region can truly be proud of. Last year was without a doubt a successful year for

the UAE Cancer Congress. It attracted approximately 700 delegates not only from the gulf region but also from the

Asia pacific and European regions. It boasted a fantastic scientific program that had something for everyone. And

now with 2012 upon us, our whole team welcomes you back to the UAE Cancer Congress 2012.

This year we continue our theme of Promoting Excellence in Oncology with the principal goal of promoting mul-

tidisciplinary care of patients suffering from cancer. Our program this year boasts top regional and international

faculty who have come together to bring you a scientific program that you will truly enjoy. Our program will have

didactic lectures, debates, challenging case presentations and oral presentations of the best research submitted

from the region. We continue to develop our surgical oncology workshops making them as hands on and interactive

as possible.

The goals of the UAE Cancer Congress have stayed the same since its conception principally to bring the best

academic congress to the region as well as support research. Last year, we had the first research grant awarded.

We continue this year with the same goals and will continue to support education, research and training and to that

end numerous best abstract awards and travel grants will be made available. Abstracts and grants submitted will

also undergo a careful review process from our fantastic scientific committee. This year we have also joined hands

with the journal of cancer which will afford the opportunity for publication of the top abstracts submitted.

Overall this year will, I am sure, prove to be an engaging experience for all attendees and will afford plenty of net-

working opportunities.

Please visit the website and follow our /uaecc2012 or like us on /uaecancercongress to be

kept abreast of upcoming exciting updates.

Best Regards,

Shaheenah Dawood Congress PresidentMedical OncologistDubai, UAE

Dear Colleagues,


Organizing Committee

Shaheenah DawoodPresident of the Congress

Dubai HospitalUAE

Aladdin Maarraoui, MD, FACPClinical Associate Professor

Gulf Medical UniversityConsultant and Chief of Hematology/Oncology

Mafraq HospitalUAE

Bassim Al BahraniSr. Consultant Medical Oncologist & Head

of Medical Oncology DepartmentNational Oncology Cancer

Royal HospitalOman

Dhairyasheel SavantConsultant Surgical Oncologist

Reconstructive & Microvascular SurgeonIndia

Alex Chang , MD CEO & Medical Director

John Hopkins Singapore Interna-tional Medical Centre

Singapore

Alya Al Mazrouei Consultant Surgeon

General Surgery Department Rashid Hospital

Dubai, UAE

Aly Abdel RazekExecutive Director

Gulf International Cancer Center Chief of Radiation Oncology

UAE

Dia Trad, MD Tawam Hospital (affiliated with

Johns Hopkins)Al Ain, UAE

Bhawna SirohiArtemis Health Institute

India

Faisal Badri, M.D. F.R.C.S. Consultant & Head of General

Surgery Department Rashid Hospital

Dubai, UAE


Organizing Committee

Faisal Badri, M.D. F.R.C.SConsultant & Head of General Surgery

Department Rashid HospitalDubaiUAE

Mikael Hartman Consultant, Breast and Trauma Surgery, NUH, Assistant Professor, Department of

Epidemiology and Public Health, NUSAdjunct Staff, Department of Medical Epi-demiology, Karolinska Institute, Sweden

Singapore

Waleed HassenChief of Pediatric Surgery

Tawam HospitalAl AinUAE

Gabriel IonescuSenior Consultant

Chief Division Pediatric Surgery at Tawam Hospital

UAE

Hamdy A. Azim Prof. of Clinical Oncology

Cairo UniversityChairman of Cairo Oncology Center

(Cairo Cure)Egypt

Vineet GuptaDiplomate American Board (Int Medi-cine, Hematology, Med.Oncology)

Group Medical DirectorHealth Care Global Enterprises Ltd

India

Gilberto de Lima Lopes, JrSenior Consultant in Medical Oncology, Assistant Director

for Clinical Research, Assistant Professor of Oncology

Johns Hopkins International Medical Centre, Singapore

Sana Al-SukhunDiplomat American Board of Internal

Medicine/Medical Oncology & Hematology, Assistant Professor of

Medicine, Faculty of MedicineUniversity of Jordan

Jordan


Scientific Committee

Alya Al Mazrouei Consultant Surgeon

General Surgery Department Rashid hospital, Dubai

UAE

Azza Adel Hassan, MD Program Director, Palliative Care Program

Consultant, Medical OncologyAssistant Professor of Clinical Medicine,

Weill CornellHamad Medical Corporation

Qatar

Dhairyasheel Savant Consultant Surgical Oncologist

Reconstructive & Microvascular SurgeonIndia

Ana Maria Gonzalez Angulo, MDAssociate Professor

Dept. of Breast Medical Oncology Dept. of Systems Biology

The University of Texas M. D. Ander-son Cancer Center

USA

Ayman AllamConsultant, Palliative/Medical

OncologyAl Amal Hospital

Axel GrotheyProfessor of Oncology &

ConsultantMayo Clinic Cancer Center

USA

C S Pramesh, MS, FRCSAssociate Professor,

Thoracic Surgery, Department of Surgical Oncology Convener,

Thoracic Oncology Disease Management group

Tata Memorial CentreIndia

Belal El-HawwariConsultant Radiation Oncologist

Section Head, Radiotherapy Departement

King Hussien Medical CityJordan

Faisal Badri, M.D. F.R.C.S. Consultant & Head of General

Surgery DepartmentRashid Hospital Dubai

UAE

Hamdy A. Azim Prof. of Clinical Oncology

Cairo UniversityChairman of Cairo Oncology Center

(Cairo Cure)Egypt

George Blumenschein, MDAssociate Professor

Thoracic/Head & Neck Med Onc, The University of Texas MD Anderson Cancer

USA

Hassan JaafarMedical Consultant

Tawam Hospital (affiliated with Johns Hopkins)

Al AinUAE


Heba El-Zawahry M.DProf. Medical OncologyNational Cancer institute

Egypt

Muhammad Ali Chaudhry, MDMedical Director

Tawam Molecular Imaging Center, UAEClinical Assistant Professor of Radiology

Johns Hopkins University School of Medicine

USA

Maroun Khoury, MDConsultant Hematology / Oncology

DubaiUAE

Pedro T. RamirezThe University of Texas MD Anderson

Cancer CenterUSA

Hanan Hamed, MD CairoEgypt

Mufid El Mistiri, MDs Consultant Medical Oncology

Director of Qatar Cancer Registry, NCCCR, Assistant Professor of Clinical Medicine,Weill Cornell

Medical CollegeQatar

Kakil Ibrahim RasulCABM, FRCP Edin, ESMOAssociate Prof. of Clinical

Medicine, Weill Cornell Medical College in Qatar, Senior

Consultant Haem/Oncology

Mohd Ussama Al HomsiHamad Medical Corporation

DohaQatar

Pankaj Chaturvedi, MS FAIS FICS FACS MNAMSAssociate Professor, Head

and Neck DepartmentTata Memorial Hospital,

India

Hesham El GhazalyProfessor of Clinical Oncology

Ain Shams UniversityEgypt

Nagi S. El Saghir, MD, FACPProfessor of Clinical Medicine

Director, Breast Center of ExcellenceNK Basile Cancer Institute

American University of Beirut Medical Center, Beirut

Lebanon

Michael L. Kendrick, M.D. Chair, Division of GI and General Surgery, Associate Professor of Surgery Mayo Clinic College of

Medicine, USA



Ren Adam Centre Hpato-BiliairePaul Brousse Hospital

France

Shona Nag Jehangir Hospital

India

Rebecca Dent Consultant

Dept of Medical OncologyNational Cancer Centre

Singapore

Vineet Gupta, MD Diplomate American Board (Int Medicine, Hematology,

Med.Oncology) Group Medical Director, Health Care Global

Enterprises LtdIndia

Shah NumaniAmerican Hospital

DubaiUAE

Shailesh V. Shrikhande Associate Professor of

Surgery, GI & HPB Surgical Oncology, Tata Memorial

Centre, India

Sami Ahmad Khatib, MD Consultant Clinical Oncologist

AmmanJordan

Sudeep Gupta, MD, DM Professor of Medical Oncology

Tata Memorial HospitalIndia

Rabab Gaafar, MDProf Medical OncologyNCI, Cairo University



Venue & Exhibition Layout

3x3

3x3

3x3

4x3

3x3

3x3

Plen

ary

Room

Coffe

eSt

ation

Pilla

r

ENTR

ANCE

ENTR

ANCE

ENTR

ANCE

ENTR

ANCE

ENTR

ANCE

ENTR

ANCE

119

3x3

LILLY

Boeh

ringe

rIng

elhein

129

7BM

S5 S

irtex

Pierre

Fabre

3x3

NeoB

iocon

3x3

Biolo

gix

AstraZen

eca5x

3

Sano

5x3

Nova

rtis

6x3

EISA

IME

NA5x

3

6x3

3x3

3x3

3x3

14AM

GEN

6x3

15

1718

GSK

5x3

13Ro

che

Poste

r Pres

entat

ion

MSD

3Ne

w Brid

ge4

Nestl

e6

3x3

Taw

am

Mol

ecul

arIm

agin

gCe

nter

8

3x3

Jans

sen

Atlas

Me

dical

1920

21

23

6x3

Actav

is

16

10

3x3

3x3

24

3x3

Onco

logy

Nurs

ing

Socie

ty

SHAM

SRe

serve

d

BGIC

S

EMEA

CRPu

re H

eart


Brea

kout

Ses

sion

sA

l Bar

aha

1 - 3

Entra

nce

Entra

nce

Entra

nce

Entra

nce

From the Lobby

Med

ia De

sk


Programme at a Glance

07:00

08:00

09:00

10:00

11:00

12:00

13:00

14:00

15:00

16:00

17:00

18:00

11th

Oct

201

2Da

y 113

th O

ct 2

012

Day 3

12th

Oct

201

2Da

y 2

08:00

07:00

09:00

10:00

11:00

12:00

13:00

14:00

15:00

16:00

17:00

18:00

Meet

The P

rofes

sor

Sess

ion I

Al Ra

s 3

Brea

st Ca

ncer

Sess

ion I

Al Ra

s 3

ONS Session - Amwaj 2

GI Surgical Session

with Rene Adam

Al Baraha 2

GI Session

Al Baraha 2

Breast Surgical Oncology Workshop

Al Ras 3

Nutrition Workshop

Amwaj 1

ONS Session

Amwaj 2

Gyne Oncology Session II - Al Baraha 1

Breast Cancer Session III - Al Ras 3

Head & Neck Oncology Session I

Al Majlis

Cancer Imaging Session

Al Baraha 3

Head & Neck Oncology Session II

Al Baraha 1

Thur

sday

Frid

aySa

turd

ay

GI Surgical Oncology Workshop

Al Baraha 2

ONS Session - Amwaj 2

Registration - Al Ras 1 & 2 Foyer

Exhibition & Coffee Breaks - Al Ras 1 & 2

Lung Cancer Session

Al Ras 3

Publication Workshop

Al Baraha 1

Lunc

h Bre

ak

Open

ing C

erem

ony

Registration - Al Ras 1 & 2 Foyer

Exhibition & Coffee Breaks - Al Ras 1 & 2

Registration

Exhibition & Coffee Breaks

Lunc

h Bre

ak

Gyne Oncology Session I

Al Baraha 1

Lunc

h & Pr

ayer

Bre

ak

Breast Cancer Session II

Al Ras 3

Palliative Care Workshop

Amwaj 2


Scientific Programme

THURSDAy, 11th OCTOBER 2012 07:00 09:00 Registration & Coffee

07:30 17:00 ONS Session - Amwaj 2

09:00 12:00 Publication Workshop - Al Baraha 1

09:00 14:00 Nutrition Workshop - Amwaj 1

11:30 12:00 Opening Ceremony - Al Ras 3

Lung Cancer Session - Al Ras 3

Breast Cancer Session I - Al Ras 3

Session Chairs: Amgad El Sherif, UAE C S Pramesh, India Maroun Khoury, UAE

08:00 - 08:30 Screening in Lung Cancer Abdul Rahman Jazieh, KSA

08:30 - 09:00 Controversies in Management of early Lung Cancer C S Pramesh, India

09:00 - 09:30 Controversies in Radiation Therapy: Treatment options for Medically Unfit Patients with early NSCLC Joost Nuyttens

09:30 - 10:30 Controversies in Chemotherapy

Personalized Therapy in NSCLC Past, Present and Future George Blumenschein, USA

New Algorithm of Treatment in Advanced Non Small Cell Lung cancer - Mehdi Shahidi, UK Is there still room for Improvement?

10:30 - 11:30 Case Discussions

Moderator Kumar Prabhash, India Panel Members: Amgad El Sherif Nasser Al-Dhaibani, UAE Maroun Khoury, UAE Joost Nuyttens George Blumenschein, USA C S Pramesh, India

12:00 - 13:00 Lunch Break

Breast Session 1: Trials and Tribulations of Metastatic Breast Cancer Chairs: Rebecca Dent, Singapore I Ahmed Saadeddin

13:00 -13:20 How Should we Overcome Endocrine Resistance in 2012? Jose Baselga, USA

13:20 -13:40 Case Presentation: A 35 Year Old Pre Menopausal with Hormone Receptor Hamdy Abdul Azim, Egypt Positive, HER2 Negative Metastatic Breast Cancer. What are the Burning Issues? 13:40 14:00 Having HER2 Positive Breast Cancer: More Options than Answers? Paul Ellis, UK

14:00 14:20 Case Presentation: How to Approach a Woman with Metastatic Triple Negative Sudeep Gupta, India Breast Cancer. Is there Anything Novel in 2012?

14:20 -14:40 Novel Systemic Approaches to Management of Brain Metastases: Cliff Hudis, USA Are We There Yet?



14:40 15:00 Can MBC be Cured in 2012? Omal Khair Abulkhair, KSA

15:00 15:20 Coffee Break

Breast Session 2: Controversies with Neoadjuvant Treatment of Breast Cancer (A Joint Symposium with the BGICC Group) Chairs: Salim Chaib Rassou, UAE I Houriya Kazim, UAE

15:20 15:40 Defining the Role of the Radiologist in the Multidisciplinary Management of a Naglaa Abd El Razek, Egypt Woman Receiving Pre Operative Chemotherapy 15:40 16:00 How Best to Assess the Axilla in a Woman Receiving Pre operative Mehra Golshan, TBvA Chemotherapy: Is There a Right Way? 16:00 16:20 Extending Indications of BCS for Locally Advanced Breast Cancer Omar Zakaria, Egypt

Debate: Should all Women Receive Pre operative Chemotherapy16:20 16:30 Yes: Ana Maria Gonzalez Angulo, USA 16:30 16:40 No: Cliff Hudis, USA

16:40 17:10 Case Presentation: Tracing the Multidisciplinary Management of a Woman Hesham El Ghazaly, Egypt Receiving Pre Operative Chemotherapy 17:30 19:00 Meet the Professor Session (Limit 50 People) Chairs: Sudeep Gupta, India I Norbit Dreier, UAE Theme: Whats New and Groovy in the Management of MBC?

17:30 18:00 Is Chemotherapy a thing of the Past for Hormone Receptor Positive MBC? Jose Baselga, USA Interactive Patient Case Study 18:00 18:30 Trastuzumab, Pertuzumab, TDMI or Lapatinib: When, Where and How? Cliff Hudis, USA Interactive Patient Case Study 18:30 19:00 Heavily Pre Treated Patient with MBC: What is new on the Horizon? Edith Perez, USA Interactive Patient Case Study

FRIDAy, 12th OCTOBER, 2012

07:00 09:00 Registration & Coffee

08:00 - 12:00 Palliative Care Workshop - Amwaj 2

Head and Neck Cancer Session

08:00 - 08:20 Role of Imaging: Radiotherapy Perspective Nasser Al-Dhaibani, UAE 08:20 - 09:00 Role of PETCT Mohei Abouzied, UAE

09:00 - 09:40 Multifunctional MRI: Applications and Challenges in Breast, Head & Neck Abhishek Mahajan, India and Pelvic Oncology

09:40 - 14:00 Breast Cancer Session

09:40 - 10:20 Establishing a Mammography Program: Lessons from Egypt Dorria Salem, Egypt

10:20 - 11:00 Screening Mammography Seema Kembhavi, India

11:00 - 11:40 Role of Sonography Seema Kembhavi, India

10:00 - 10:20 MR Mammography Atif Zaheer, USA

Cancer Imaging Session - Al Baraha 3



11:40 - 12:40 Lunch & Prayer Break

12:40 - 13:20 MR Mammography Atif Zaheer, USA

13:20 - 14:00 Role of PET/CT Muhammad Ali Chaudhry, UAE

14:00 - 15:00 PETCT/Coloretal Session

14:00 - 14:20 PETCT Role in Radiotherapy Planning Maryam Aslani, UAE

14:20 - 15:00 Rectal Cancer Staging Imaging Atif Zaheer, USA

15:00 - 15:20 Coffee Break

15:20 - 17:00 Pelvic Cancers Session

15:20 - 16:00 Cervical Cancer Staging: MRI Seema Kembhavi, India

16:00 - 16:40 MRI of the Prostate Atif Zaheer, USA

16:40 - 17:00 Role of PETCT in Cervical Cancer Staging Muhammad Ali Chaudhry, UAE

Gynecologic Oncology Session - Al Baraha 1

07:50 08:00 Introduction Nicole Fleming (USA)

Updates and Controversies in Ovarian Cancer Moderator: Nicole Fleming (USA)

08:00 08:25 Novel Targeted Therapies in Ovarian Cancer Speaker: Sana Al Sukhun, MD, MSc. (Jordan) Discussion (5 min)

08:25 08:55 Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: Is this the New Standard of Care? PRO: Shona Nag (India) CON: Luis Chiva (Spain) Discussion (5 min)

08:55 09:15 Secondary Cytoreductive Surgery in Ovarian Cancer Speaker: Francesco Raspagliesi (Italy) Discussion (5 min)

09:15 09:45 Updates on Medical Management of Recurrent Ovarian Cancer Speaker: Antonio Gonzalez Martin (Spain) Discussion (5 min) 09:45 10:15 Current Management of Rare Ovarian Tumors Speaker: Sudeep Gupta (India) Discussion (5 min)


Emerging Therapies in Endometrial Cancer Moderator: Antonio Gonzalez Martin (Spain)

10:30 10:55 The Role of Lymphadenectomy and Lymphatic Mapping in Endometrial Cancer Speaker: Francesco Raspagliesi (Italy) Discussion (5 min)

10:55 11:20 Updates on Medical Management of Advanced/Recurrent Endometrial Cancer Speaker: Sana Al-Sukhun, MD, MSc. (Jordan) Discussion (5 min)



11:20 11:50 Role of Tomotherapy in Treatment of Gynecologic Malignancies Speaker: Luis Schiappacasse (France) Discussion (5 min)

11:50 13:00 Lunch & Prayer Break

13:00 15:00 Surgical Video Symposium Moderators: Nicole Fleming (USA) Luis Chiva (Spain)

Role of Minimally Invasive Surgery in Gynecologic Oncology Speaker: Nicole Fleming (USA) Surgical Video Session (15 mins/video) r Surgical Tips in Upper Abdominal Procedures (Luis Chiva) r Retroperitoneal Debulking and Vascular Complications (Luis Chiva) r Nervous and Lymphatic Anatomy in Para Aortic Lymphadenectomy (Francesco Raspagliesi) r Robotic Radical Trachelectomy for Cervical Cancer (Nicole Fleming) r Lymphatic Mapping and Sentinel Lymph Node Biopsy (TBD) Video Submissions Award Video Winner #1


15:15 16:15 Tumor Board Moderator: Nicole Fleming (USA) Panelists: Luis Chiva (Spain) Sudeep Gupta (India) Sana Al Shukun (Jordan) Luis Schiappacasse (France)

Clinical Update in Cervical Cancer Moderator: Sudeep Gutpa, India

16:15 16:35 Early Stage Cervical Cancer: Updates on Fertility Preservation Speaker: Nicole Fleming (USA) Discussion (5 min)

16:35 17:00 Treatment of Locally Advanced Cervical Cancer Speaker: Antonio Gonzalez Martin (Spain) Discussion (5 min)

17:00 17:30 Use of Targeted Agents in Cervical Cancer Speaker: Shona Nag (India) Discussion (5 min)

17:30 17:45 Conclusion Nicole Fleming (USA)



09:00 -09:30 Interactive Patient Case Presentation (Brain Metastases) Rebecca Dent, Singapore Panel Members: Meteb Al-Foheidi, UAE Salim Chaib Rassou, UAE Norbit Dreier, UAE Nouri Benini, UAE

Breast Session 3: The Past, Present and Future of Breast Cancer Treatment Chairs: Meteb Al-Foheidi, UAE I Irfan Ul Haq I Salim Chaib Rassou, UAE

09:30 10:00 The Triumphs and Pitfalls of 2011/2012 David Miles, UK 10:00 10:20 Advances in Breast Cancer Biology: What we have Learnt , What we Know, Jose Baselga, USA What we Look Forward to 10:20 -10:50 The Treatment Cut Off for FISH HER2 Levels: The Confusion Stops Here! Edith Perez, USA

10:50 -11:10 Molecular Assessment and Patient Selection for Adjuvant Therapy: Can we Ana Maria Gonzalez- Avoid Chemotherapy? Angulo, USA 11:10 11:30 What is the Role of Post Mastectomy Radiation among Women with 1 to 3 Aly Abdel Razek, UAE Positive Lymph Nodes in 2012 12:00 12:30 Lunch & Prayer Break

12:30 - 13:30 Interactive Patient Case Discussion: Moderator, Vineet Gupta Panel Members: Aly Abdel Razek, UAE Bhawna Sirohi, India Edith Perez, USA Hamdy Abdul Azim, Egypt Jose Baselga, USA Paul Ellis, UK Shah Numani, UAE Case 1: Endocrine Resistant Breast Cancer Case 2: Oncotype DX for Node Positive Breast Cancer: Are We There Yet Case 3: Triple Negative Breast Cancer

Breast Session 4: Controversies and Debates of 2012 Chairs: Vineet Gupta, India I Nouri Benini, UAE I Ramanujam Singarachari, UAE

13:30 -13:50 Incorporating Bisphosphonates among Women with Early Stage Breast Cancer Yes: Nagi El Saghir, Lebanon No: Sudeep Gupta, India

13:50 - 14:10 Role of Antiangiogenic Agents: Where Did We Go Wrong? David Miles, UK

14:10 -14:30 Case Debate: 45 Years Old Pre Menopausal Woman with Grade II T1a N0M0 HER2 Positive, Hormone Receptor Positive Breast Cancer There is a Role of Adjuvant Trastuzumab: Jose Baselga, USA There is no Role for Adjuvant Trastuzumab: David Miles, UK 14:30 14:50 Dual HER2 Blocking in a Woman with HER2 Positive MBC: Do We Need to add Chemotherapy? Yes: Edith Perez, USA No: Paul Ellis, UK

Breast Cancer Session II - Al Ras 3



Head & Neck Session I - Al Majlis 12:00 - 13:00 Lunch and Poster Viewing Judges r Ravinder Deo, India r Chirag Shah, India r Soma Sundaram, Russia r Sankar Srinivasan, India r Biswajit Bhattacharya, Bangladesh

13:00 - 13:15 Welcome Speech by Program Chairperson Pankaj Chaturvedi, India

13:15 - 13:45 Pearls of Wisdom Chairpersons: Sangita Bhandari, Nepal I Ravinder Deo, India r How to Save the Recurrent Laryngeal Nerve and Superior Laryngeal Nerve during Thyroid Surgery - Balazs B Lorincz, Germany r How do I Save the Important Nerves during Surgery (Facial and Spinal Accessory) Dhairyasheel Savant, India r How to Manage the Side effect RT/CT in HNSCC - Arif Jamshed, Pakistan

13:45 - 14:00 Q & A

14:00 - 14:40 Part - I: Important Issues in the Management of HNSCC Chairpersons: Raghav Dwivedi, UK I Ajit Veniyoor, India r Precision Medicine Approaches in the Curative and Palliative Treatment of Head and Neck Cancer - Tanguy Seiwert, USA r What is Best Management of Neck in T1/2 N0 Patients - Neck Dissection or Observation? - Gauri Pantvaidya, India r Management of Laryngeal Fold Paralysis - Gayle Woodson, USA r Laser Surgery for locally Advanced Lesions in Larynx and Pharynx - Cesare Piazza, Italy

14:40 - 15:00 Q & A

15:00 - 15:15 Coffee Break15:15 - 16:15 PART II: Important Issues in the Management of HNSCC Chairpersons: Shishir Shetty, India I Vedant Kabra, India I Hussain Abdul Rahman, UAE r Transoral Robotic surgery - Challenges and Opportunities - Cyrus Kerawala, UK r Management of Nutrition during treatment of HNSCC - Shaesta Mehta, India r Optimal Imaging in HNSCC - Shashikant Juvekar, India r Prevention and Screening of HNSCC - Vishal Rao, India

14:50 15:10 Case Debate: 35 Years Old Pre Menopausal Women with a Grade III T2N0M0 Triple Receptor Negative Breast Cancer: Are Anthracylines Necessary? Yes: Vineet Gupta, India No: Rebecca Dent, Singapore

15:10 15:30 Case Debate: 55 Years Post Menopausal Woman with pT2N1M0 IDC, ER/PR Positive, HER2 Negative. Had Surgery, Adjuvant Chemotherapy and Adjuvant XRT. Needs to be Started on Adjuvant Endocrine Therapy. Which Agent First? Is Longer Better? Aromatase Inhibitor First Ana Maria Gonzalez, USA Tamoxifen followed by Aromatase Inhibitor Nagi El Saghir, Lebanon

15:30 15:50 Forgoing ALND in Sentinel Node Positive Women: Should we be more Cautious? S V Deo, India 15:50 16:10 Case Debate: 65 years Old Lady with Newly Diagnosed MBC. ER/PR Positive. HER2 Negative. Has Radiological Evidence of Extensive Bone Metastases The Case for Denosumab: Hamdy Abdul Azim, Egypt The Case for Zoledronic Ascid: Bhawna Sirohi, India

16:10 16:30 Biopsy of a Patient with MBC: When to Order and How to Integrate Results Paul Ellis, UK



16:15 - 17:15 Chemotherapy in Head and Neck Cancers Revisted Moderator: Chetna Bakshi I Sanker Srinivasan, India r Palliative Chemotherapy - When, What, How? - Sandeep Goyle, India r Induction Chemotherapy - What is the Current Evidence? - Ashish Bakshi, India r Anaplastic/Medullary Carcinoma of Thyroid - Role of Chemotherapy - Shailesh Bondarde, India r Metronomic Therapy - Does it have a Role? - Nirmal Raut, India

GI Surgical Oncology Workshop Session - Al Baraha 2

Chairs: Harit Chaturvedi, India I Jorg Kleeff, Germany

13:00 - 13:20 Laparoscopic Pancreatic Surgery: Indications and Outcomes Michael Kendrick, USA

13:30 - 13:50 Evidence Based Surgical Management of Pancreatic Tumors Shailesh V. Shrikhande, India

14:00 - 15:00 Master Videos r SMA First Technique Shailesh V. Shrikhande, India r Laparoscopic Whipple Resection Michael Kendrick, USA r Right Hepatectomy Mahesh Goel, India r VATS Esophagectomy K. George, India r 2 Field Esophagectomy Jorg Kleeff, Germany


15:15 - 17:15 Interactive Case Based Discussion Chairs: Michael Kendrick, USA I Harit Chaturvedi, India

r Neoadjuvant Approaches in GI Cancers Bhawna Sirohi, India r Cystic Tumors of the Pancreas Shailesh V. Shrikhande, India r Emerging Multimodality Approach in HCC Mahesh Goel, India r mCRC: Whats New 2012 TBA

12:30 - 14:30 ONS Session - Amwaj 2

GI Session - Al Baraha 2

08:00 13:00 ONS Session - Amwaj 2

SATURDAy 13th OCTOBER, 2012

07:00 09:00 Registration & Coffee

07:30 - 09:00 Meet the Professor Session: Ren Adam, France Moderators: Shailesh V. Shrikhande, India I Bhawna Sirohi, India

GI Session I: Hot Topics of 2012 Chairpersons: Eric Van Cutsem, Belgium I Norbit Dreier, UAE

09:00 - 09:20 The Positive, the Negative and the Maybe of 2011 and 2012 Marc Peters

09:25 - 09:45 Gene Expression Profiling for Colon Cancer: Is it Ready for Prime Axel Grothey, USA Time Use?

09:50 - 10:10 The Flop Side of Adjuvant Targeted Therapy. Is There a Way Forward? Marc Peters

10:15 10:40 Debate 1: Xeloda or Infusional 5FU for Metastatic Colon Cancer No Difference: Ranga Rao, India There is a Difference: Axel Grothey, USA



Scientific Programme11:00 - 11:20 Whats New on the Horizon for Metastatic Colon Cancer? Eric Van Cutsem, Belgium

11:25 - 11:50 Debate 2: A 55-year old gentleman presenting with a Primary Lesion in the Colon Non-Obstructing growth but Occasional Bleeding per Rectum. Staging reveals four Liver Metastatic Lesions that are considered to be Borderline Resectable Surgery first: Ren Adam, France Chemotherapy first: Norbit Dreier, UAE

11:55 - 12:20 Debate 3: Is Post Operative Chemotherapy Required in Patients with Rectal Cancer attaining a pCR Yes: Eric Van Cutsem, Belgium No: Bhawna Sirohi, India

12:20 - 13:00 Lunch Break

GI Session 2 Chairpersons: Ranga Rao, India I Mahesh Goel, India

13:00 - 13:20 Stop and go or Continuous Bevacizumab: Is There a Right Way? Axel Grothey, USA

13:25 - 13:45 The Ideal Chemotherapy Backbone to Biologics: Do we Know What it is? Marc Peters

13:50 - 14:10 Are all KRAS Mutations the Same Eric Van Cutsem, Belgium

14:15 - 14:35 Neoadjuvant Radiotherapy in Low Rectal Cancer Syed Mansoor Hasnain, UAE

14:40 - 15:00 Management of Peritoneal Metastases in CRC Faheez Mohamed, UK


15:20 - 16:20 Interactive Case Based Session Moderator: Marwan Khoury, UAE Panel Members: Axel Grothey, USA Eric Van Cutsem, Belgium Marc Peters Michael Kendrick, USA Shailesh Shrikhande, India Ren Adam, France Case 1: KRAS Wild Type Metastatic Colorectal Cancer Case 2: KRAS Mutant Metastatic Colorectal Cancer Case 3: Stage III Colorectal Cancer Case 4: Colorectal Cancer and Liver Metastases

Breast Surgical Oncology Workshop Session - Al Ras 3

08:25 08:30 Introduction and Overview Dhairyasheel Savant, India Session I

08:30 09:15 Video Session: Ductoscopy Vinay Deshmane, India Sentinel Node Biopsy in Breast Cancer Surgery TBA Intraoperative Radiotherapy in BCT Sanjay Sharma, India Oncoplastic Breast Surgery Vinay Deshmane, India LD Flap Reconstruction following MRM Dhairyasheel Savant, India

Session II

09:20 09:35 Oncologic Considerations in Breast Reconstruction following BCT/MRM Dhairyasheel Savant, India


Scientific Programme09:35 09:50 Breast Cancer Surgery: Whats Being Discussed at the Major Meetings Vinay Deshmane, India


Session III

10:00 12:00 Case Capsules and Discussion: Cases Covering Gamut from Non Palpable to Early to LABC to Advanced and Metastatic Moderator: Sanjay Sharma, India Panelists: Faraz Khan, Medical Oncologist, UAE Houriya Khazim, Breast Surgeon, UAE Seema Kembavi, Imaging, India Salim Chaib Rassou, Radiation, UAE Vinay Deshmane, Surgeon, India 12:00 13:00 Lunch Break

Session IV

13:00 13:45 Case Discussion - Surgical Unit, Dubai Hospital

13:45 14:00 Concluding Remarks and Summation

Head & Neck Session II - Al Baraha 1

09:00 - 10:00 What is New in Head and Neck Cancers Moderators: Suraj Pawar, India I Vedant Kabra, India

r Surgery - K A Pathak, Canada r Radiotherapy - Namrata Satyapal, Oman r Chemotherapy - Tom Robbins, USA r Chemoprevention - Nagao Toru, Japan

10:00 - 10:45 Grand Debate - Is Chemo-Radiotherapy the Best Organ Preservation Strategy for HNSCC? Moderators: Arif Jamshed, Radiation Oncologist, Pakistan I Tanguy Seiwert, USA

r For - Kumar Prabhash, Medical Oncologist, India (15 mins) r Against -Vedang Murthy, Radiation Oncologist, India (15 mins)

10:30 - 10:45 Q & A


11:00 - 12:00 Panel on Thyroid Cancer Moderator: Devendra Chaukar, Surgeon, India

Panelists: r Vikram Sanghvi, Surgical Oncologist, India r Sharmistha Gupta, Radiologist, UAE r Dauran Adilbay, Surgeon, Kazakhstan r Mandar Deshpande, Surgeon, India r Aly Abdel Razek, Radiation Oncologist, UAE r Gouri Pantvaidya, Surgeon, India r Nilesh Lok, Medical Oncologist, India

12:00 - 13:00 Panel on Challenging Problems in Management of HNSCC Moderator: Pankaj Chaturvedi, India

Panelists: r SVS Deo, Surgeon, India r Tarini Sahoo, Medical Oncologist, India r Shashikant Juvekar, India r Andrei Karpenko, Surgeon, Russia r Deepak Sarin, Surgical Oncologist, India r Salim Chaib Rassou, Radiation Oncologist, UAE r Jamil Hyder, Surgeon, Oman r Vanita Noronha, Medical Oncologist, India


Faculty Profile

ONS Workshop

Mary Laudon Thomas is the hematology clinical nurse specialist in at the Veterans Affairs Medical Center in Palo Alto, California and is also an Associate Clinical Professor in the School of Nursing at the University of California, San Francisco. She obtained her Bachelor of Science in Nursing Degree from the University of Wisconsin and her Master of Science Degree from the University of California, San Francisco, specializing in Oncology Nursing. She is an Advanced Certified Oncology Nurse. Ms. Thomas is a member of the Nurse Advisory Board of the International MDS Foundation, and is active in the Eastern Cooperative Oncology Group, where she is a member of the Nursing, Symptom Management, and Leukemia Committees. She has developed the quality of life and geriatric assessment component of a clinical trial treating AML in the elderly for ECOG and a quality of life section for a CLL treatment protocol submitted for approval.

Ms. Thomas has been a member of the Oncology Nursing Society for almost 30 years. She has reviewed abstracts for the annual congress and is a member of the planning committee for the Regional Hematology Conferences for nurses in the U.S. Ms. Thomas is a representative of the VA Office of Nursing Service Advanced Practice Nurse Advisory Group where she co-chairs the planning committee for the 2013 VA APN Conference and a member of the VA Office of Nursing Service Evidence Based Practice Goal Group. She has presented to patients, nurses, physicians and the community on local, national and international levels.

Jean Ridgeway is an Advanced Practice Nurse/Nurse Practitioner at the University of Chicago Medical Center in Chicago, Illinois, USA. She works exclusively with the adult malignant haematology and stem cell transplant programs in the outpatient setting. She also teaches both nationally in the USA and internationally to nurses about leukaemias, lymphoma, multiple myeloma, myelodysplastic syndromes and stem cell transplant. She has authored various articles and book chapters on these topics. She lives in the city of Chicago where she is an adjunct faculty at the University of Illinois College of Nursing and Loyola University College of Nursing.

Mary Thomas, RN MS AOCNHematology Clinical Nurse SpecialistVA Palo Alto Health Care System, California, USA

Jean Ridgeway, RN APN NPC MSN AOCNNurse PractitionerUniversity of Chicago, Illinois, USA


Faculty Profile

Clare is Consultant Dietician at The Royal Marsden NHS Foundation Trust and has specialised in working with oncology patients for over 20 years. Her work has included advising patients with different cancer diagnoses including head and neck, gastrointestinal and breast cancer. More recent work includes working with patients who have late gastrointestinal effects following treatment for cancer in a specialised outpatient setting. Outside her work at The Royal Marsden she is on the Clinical Advisory Board for Macmillan, a national UK cancer charity. She was also a member of the group that produced the national rehabilitation pathways in cancer and has published a cookery book on diet and cancer prevention. Clare has recently published a text book entitled Nutrition and Cancer. Clare also has a research role at the Royal Marsden, encouraging and support Allied Health Professionals to undertake research in the area of rehabilitation and cancer. The Department of Nutrition and Dietetics at The Royal Marsden is actively involved in research including studies on nutrition screening, dietary interventions during radiotherapy and the nutritional status and symptoms of patients with upper gastrointestinal cancer.

Lucy Eldridge is the Dietetic Team leader at The Royal Marsden. Prior to joining the Marsden in 2011 she worked for almost 15 years at Barts and the London NHS Trust working within the field of Oncology and Palliative care. As part of this role she set up and developed the dietetic service at St Josephs Hospice in Hackney. In 2009 she completed her MSc in Cancer Care. She has a keen interest in the role of nutrition in palliative care and is on the committee of the national Palliative Care Dietetic Group. She has written a chapter on nutrition and palliative care and another on the psychosocial influences on food choice of cancer patients. She is an occasional guest lecturer at Kings College, University of London for dietetic students regarding palliative care and has spoken at local and national conferences on a variety of topics.

Clare Shaw, PhD RDConsultant DietitianThe Royal Marsden NHS Foundation Trust, UK

Lucy Eldridge MSc RDDietetic Team LeaderNutrition & Dietetic DepartmentThe Royal Marsden NHS Foundation Trust, UK

Nutrition Workshop


Faculty Profile

Abdul Rahman Jazieh, MD, MPHChairman, Oncology DepartmentProfessor, King Saud University for Health SciencesNational Guards health Affairs, Riyadh, KSA

C S Pramesh, MS, FRCS Associate Professor, Thoracic SurgeryDepartment of Surgical Oncology, Convener, Thoracic Oncology Disease Management groupTata Memorial Centre, India

Lung Cancer Session

George R. Blumenschein, Jr. is an Associate Professor of Medicine in the Department of Thoracic/Head and Neck Oncology at The University of Texas MD Anderson Cancer Center, Houston, TX. Dr. Blumenschein graduated from The University of Texas Medical School of Houston and completed a fellowship at The University of Texas MD Anderson Cancer Center, where he later accepted his current post. He has received certification from the American Board of Internal Medicine and the American Board of Medical Oncology.

Dr. Blumenschein has a keen clinical interest in the development of novel therapies for head and neck cancers, small cell lung cancer and non-small cell lung cancer (NSCLC). His research has a particular focus on compounds with novel mechanisms of action, including inhibitors of epidermal growth factor, vascular endothelial growth factor and histone deacetylase. In pursuing these inter-

Joost Nuyttens

George R. Blumenschein, Jr., MD Associate Professor of MedicineThoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, USA


Faculty Profile

ests, he has taken on the role of Principal Investigator for several phase II and phase III studies to assess the efficacy of targeted agents in NSCLC. He recently presented trial data at the 13th World Conference on Lung Cancer, 2009 in San Francisco, CA, and has published work in several prestigious journals, including Journal of Clinical Oncology, Clinical Lung Cancer and Cancer.

Dr Mehdi Shahidi is the Associate Therapy Area Head, Oncology at Boehringer Ingelheim and until recently held an honorary clinical appointment at the Royal Marsden Hospital in London, UK. Prior to joining Boehringer Ingelheim in 2005, Dr Shahidi held the position of Medical Expert, Oncology at Novartis Oncology in 2004-2005 and was Medical Director of Oncology at PRA International from 2002-2004.

He spent five years as a Senior Research Fellow at the Institute of Cancer Research, Royal Marsden Hospital, where he undertook research projects in urological cancers and lymphoma, and was involved in Phase I-III clinical oncology trials and direct care of patients with cancer. Prior to that, Dr Shahidi worked as a consultant clinical oncologist in two University-affiliated hospitals in Tehran, Iran.

Dr Shahidi received his medical training at the National University Medical School, Iran, and his specialist training in Clinical Oncology at the Jorjani Medical Centre, Iran and the Royal Marsden Hospital, UK. He obtained the British Postgraduate Medical Federation Diploma in Clinical Oncology with distinction and completed the Postgraduate Course in Pharmaceutical Medicine. Additionally, Dr Shahidi is a Fellow of the Faculty of Clinical Oncology of the Royal College of Radiologists and the Faculty of Pharmaceutical Medicine of the Royal College of Physicians, London, UK.

Dr Shahidi has presented his research at numerous international oncology congresses and has been published extensively in a range of peer-reviewed journals.

Mehdi Shahidi MD, FRCR Associate Therapy Area HeadClinical Research - Clinical DevelopmentBoehringer Ingelheim, UK

Kumar Prabhash, MD, DM, ECMO, PDCR Assoc Prof, Medical OncologyTata Memorial Hospital, India


Faculty Profile

Nasser Al-Dhaibani, M.D., D.I.M., F.R.C.P.C, BRACHyRadiation Oncology DepartmentTawam Hospital, Al Ain, UAE

Maroun Khoury Consultant Hematology/OncologyAmerican HospitalDubai, UAE


Faculty Profile

Jose Baselga is the Chief of the Division of Hematology/Oncology and Associate Director of the Massachusetts General Hospital Cancer Center in Boston where he is also Professor of Medicine at Harvard Medical School. His research interests are in clinical breast cancer and in translational and early clinical research. He conducted the initial clinical trials with the monoclonal antibodies cetuximab and trastuzumab and is leading the clinical development of several new agents including pertuzumab and PI3K inhibitors. His main focus in the laboratory and in the clinic is in the area of novel anti-HER2 agents, in the identification of mechanisms of resistance to anti-HER2 agents and therapeutic approaches to target the PI3K pathway. He is also leading a number of neo-adjuvant trials in breast cancer and has been at the forefront of developing biomarker-based early and translational clinical trials.

Rebecca Dent Office of Clinical Sciences, Duke-NUS Graduate Medical School, Consultant, Dept of Medical Oncology, National Cancer Centre, Singapore

Jose BaselgaAssociate Director, MGH Cancer CenterChief, Division of Hematology/Oncology, Massachusetts General Hospital, USA

Breast Cancer Session

Hamdy A Azim is Professor of Clinical Oncology at Cairo University in Egypt. He completed his MSc in clinical oncology at the Cairo University Hospital, thereafter writing a PhD thesis on the management of non-Hodgkins lymphoma in adults. Dr Azim then obtained postdoctoral training at the Medical Oncology Department of the Institut Curie in Paris, France and at theDepartment of Adult Lymphoma and Bone Marrow Transplants, Hopital St. Louis in Paris. Dr Azim is a member of numerous societies including the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), the European Blood and Marrow Transplantation Society (EBMT), the European Society of Medical Oncology and Oncology (ESMO), the Amer-

Hamdy A. AzimProf. of Clinical OncologyCairo University, Egypt


Faculty Profile

Professor Paul Ellis studied medicine at Otago University in New Zealand before com-pleting his fellowship in Medical Oncology and his postgraduate Doctor of Medicine research degree at the Royal Marsden Hospital in London. During this time he was awarded the inaugural ASCO Fellowship Award in 1996. He took up his present post in 1997.

Between 2003 and 2005 he was Head of Medical Oncology at Guys & St Thomas and is currently Medical Director for the South East London Cancer Network. He is the author of over 70 peer reviewed scientific papers with a particular focus in the fields of breast and lung cancer. He has been on the Editorial Board of a number of oncology journals including the Journal of Clinical On-cology. His major breast cancer research interests include novel clinical research strategies in the adjuvant and neoadjuvant setting with an emphasis on the integration of novel therapies. Professor Ellis was the principal investigator and co-chair of the trial management group for the national UK Adjuvant Chemotherapy (TACT) Trial. He was also co-chair of the UK Department of Health Advisory Committee for the development of national treatment guidelines for the use of Adjuvant Trastuzumab.

Paul EllisProfessor of Medical OncologyGuys & St Thomas NHS Trust, UK

ican Society of Therapeutic Radiology (ASTRO) and the International Association of Ambulatory Infusional Chemotherapy, Paris (ADICCA). He sits on several scientific committees and has been an invited speaker in more than 100 regional and international conferences in the Middle East, Europe, USA and Asia. He served as a speaker for the ASCO online educational programme and represented the Middle Eastern Region on the ASCO International Affairs Committee from 1997 to 2002.

His main interests lie in lymphoma, breast cancer, bone metastases and translation research where he has published more than 50 papers and 100 abstracts. Dr Azim is an editor for the Journal of Clinical Lymphoma, The Lancet (Middle East edition), and the Journal of Clinical Oncology and Nuclear Medicine. He was an educational book guest editor at the annual Kasr El Aini Center of ClinicalOncology (NEMROCK) meeting, in collaboration with MD Anderson Cancer Center (MDACC) and the French National Cancer Institute (INCA) in 2006. Dr Azim serves as referee for the Annals of Oncology Journal, THE BREAST, Chemotherapy and the Journal of the Egyptian National Cancer Institute. He has been honoured with several awards including Scientist of the Year from the International Biographical Centre, Cambridge, UK (2002), the Order of Merit, Cambridge University (2002), and the Best Arab Oncologist (1997-2000) from the Lebanese Society of Medical Oncology (LSMO). Together with international leaders of government, patient advocacy leaders, cancer research organisations and corporations, Dr Azim signed the Charter of Pars against Cancer on behalf of the Arab World in February 2000.


Faculty Profile

Sudeep GuptaProfessor of Medical OncologyTata Memorial Hospital, India

Clifford A Hudis, MD is chief of the breast cancer medicine service and attending physician at Memorial Sloan-Kettering Cancer Centre (MSKCC) in New York City where he is also a professor of medicine at the Weill Medical College of Cornell University. He is co-leader of the Breast Disease Management Team at MSKCC, co-chair of the Breast Committee of the Cancer and Leukemia Group (CALGB), Treasurer of the American Society of Clinical Oncology (ASCO), chair of the Scientific Advisory Committee of the Breast Cancer Research Foundation, and an Associate Editor of the Journal of Clinical Oncology. Dr Hudis received his BA from Lehigh University and his MD from the Medical College of Pennsylvania in 1983 following the completion of a six-year combined BA and MD program. From 1983 through 1987 he trained in internal medicine at the Medical College of Pennsylvania and served as chief medical resident. His hematology/oncology training was completed at MSKCC in 1991 and since then he has been a member of the Breast Cancer Medicine Service at Memorial Hospital where he has conducted a large number of clinical trials. His research interests include drug development with a particular focus on the integration of newer agents into the treatment plan for patients with early stage disease. His current research focuses on the exploration and clinical translation of several signal transduction pathways including HER2 and COX2.

Clifford Hudis, M.DChief, Breast Cancer Medicine Service & Attending PhysicianMemorial Sloan-Kettering Cancer Centre, USA

Omalkhair AbulkhairSection Head & Consultant, Division of Adult Medical Oncology, Department of Oncology, King Abdulaziz Medical City, National Guard Health Affairs, KSAAlfa Scan Radiology Center, Egypt

Naglaa Abdel Razek, MD Assistant Prof. of RadiologyCairo University, Egypt


Faculty Profile

Dr. Gonzalez-Angulo, attended medical school at the Universidad del Cauca in Colombia and moved to the U.S. to continue her training. She completed a residency in Internal Medicine at the Mount Sinai Medical Center in Miami, and a Fellowship in Medical Oncology at the Ochsner Clinic Foundation in New Orleans. She then went to the University of Texas MD Anderson Cancer Center to specialize in Breast Cancer as she was selected as the Susan G. Komen Breast Cancer Fellow. She stayed at MD Anderson faculty and works exclusively with Breast Cancer patients and in Breast Cancer research.

She is interested in aggressive types of breast cancer including triple receptor-negative disease. Her research focuses on mechanisms of resistance to standard breast cancer therapies, and on the development of markers to predict response to treatments using functional proteomics. She is funded by the NCI, ASCO, Komen for the Cure, AACR (SU2C) and the Commonwealth Foundation for Cancer research. She is the Chair of the Endocrine Resistance Working Group and a member of the Correlative Sciences Working Group for the Translational Breast Cancer Research Consortium, and a member of the Breast Cancer Committee of SWOG and of the BIG-NABG Triple Negative Working Group. She serves as a member of the steering committee of The United States Middle EastPartnership for Breast Cancer Awareness and Research and the Partnership for Breast Cancer Awareness and Research of the Americas.

Omar Zakaria Assistant Professor of SurgerySurgical OncologyNational Cancer institute, Cairo University, Egypt

Ana Maria Gonzalez Angulo, MDAssoiciate Professorept. of Breast Medical Oncology, Dept. of Systems Biology, The University of Texas M.D Anderson Cancer Center, USA


Faculty Profile

Professor Hesham Elghazaly is the chief of oncology departments in General Organization of Teaching Hospitals and Institutes (GOTHI). He is assistant professor of clinical oncology, Ain Shams University. He is also the founder and president of BGICS - Breast Gynecological International Cancer Society - which is a society aiming at promoting optimal standards of care for patients with breast & gynecological cancers. It represents a committee of the international & national members including Medical Oncologists, Surgical Oncologists, Gynecologists, Radiotherapists, Radiologists, and Pathologists exclusively dedicated to foster international multidisciplinary collaboration to highlight the updates on evidence-based practice to reach a guideline for the management of breast and gynecological cancers by the end of 2013, also aiming to establish a specialized BGICS Journal, hoping to see its 1st volume soon.

The BGICC Breast Gynecological International Cancer Conference, www.bgicc.eg.net, is one of the main activities of the society. It is the only conference specialized in the breast & gynecological cancers in Africa & the Middle-East. Its ultimate goal is to ameliorate the prognosis and improve the quality of life of patients affected by this disease through undertaking and supporting international initiatives, sharing their experience & implementing trials and to reach aconsensus regarding the management of the breast & gynecological cancer & aiming for Women Welfare.

Prof. Elghazaly is also an active member of many international and national societies like American Society of Clinical Oncology (ASCO) and European Society of Medical Oncology (ESMO) among others. He also achieved European certification in medical oncology. He is part of different committees concerning different types of cancer as he shares in establishing the ESMO guidelines of colorectal cancer in Lugano 2010. He is also a member of International GIT and Liver society and Egyptian Forum of Liver disease (EFLD). Prof. Elghazaly is the chairman and owner of Alfa Cure Oncology Center, which is a private center highly equipped to achieve the maximum care for patients with cancer. In the way of improvement the patient need and satisfaction, the center invites high caliber international experts for patient consultation from inside and outside the center. There is also a newly added pain clinic and nutritional clinic which help patients during treatment for achievement of best quality of life.

Edith A. Perez, M.D., is the Deputy Director of Mayo Clinic Cancer Center in Florida, Vice Chair of the Alliance for Clinical Trials in Oncology, Director of the Breast Program, and the Serene M.

Hesham El GhazalyProfessor of Clinical OncologyAin Shams University, Egypt

Edith A. Perez, M. D. Deputy Director, Mayo Clinic Cancer CenterSerene M. and Frances C. Durling Professor of Medicine, USA


Faculty Profile

Professor David Miles is a Consultant in Medical Oncology at Mount Vernon Hospital in Northwood, Middlesex, where he specialises in the care of patients with breast cancer. He underwent his specialist training at Kings College London, University College London and Guys Hospital, and was awarded an Imperial Cancer Research Fund Fellowship at Guys Breast Unit. After completing his MD, he was appointed Senior Lecturer and Consultant at Guys in 1995, and he moved to his current post in 2004.

His research interests include the development and investigation of novel treatments for breast cancer and he is Principal Investigator for various national and international trials, including the AvaDo (Avastin plus docetaxel) study. He has participated as Chair and speaker in many key oncology mettings, and his publications are seen in a range of high-impact journals.

David MilesConsultant Clinical OncologistMount Vernon Hospital, UK

and Frances C. Durling Professor of Medicine at Mayo Medical School. She is a cancer specialist and an internationally known translational researcher at Mayo Clinic. Her roles extend nationally, including chairing the Breast Committee for the North Central Cancer Treatment Group, aswell as other positions within the American Association for Cancer Research, the American Society ofClinical Oncology and the National Cancer Institute.

Dr. Perez has developed, and is involved in, a wide range of clinical trials exploring the use of new therapeutic agents for the treatment and prevention of breast cancer. She also has developed studies to evaluate the role of genetic markers in the development and aggressiveness of breast cancer. Dr. Perez has authored more than 550 research articles in journals, books, and abstracts. Dr. Perez is invited frequently to lecture at national and international meetings. She serves on the editorial boards of multiple academic journals.

Dr. Perez is a recipient of the following awards: Breast Cancer Research Foundation Research Grant Award (1998-2011); Horizon Achievement Award in Cancer Research (2002); North Florida Hispanic of the Year Award (2003); Mayo Clinic Outstanding Faculty Award (2002 & 2004); Mayo Clinic Distinguished Educator Award (2003); named Serene M. and Frances C. Durling Professorship of Medicine (2006); Honorary Doctorate of Letters, University of North Florida (2006); Mayo Clinic Distinguished Investigator (2007); Florida State Biomedical Research Advisory Council (BRAC) (2009-2012); membership to Alpha Omega Alpha Honor Medical Society (2009), Mayo Clinic Outstanding Course Director (2009), and the EVE Award for Lifetime Achievement (2011).


Faculty Profile

Dr. Aly Abdel Razek is the Executive Director of The Gulf International Cancer Center and the Chief of Radiation Oncology. He graduated from Cairo University and completed his Radiation Therapy Residency at Washington University School of Medicine, St. Louis, Missouri where he joined the staff of Washington University. He contributed to four Radiation Oncology Textbooks and published many papers in the field. His area of interest is radiation therapy for prostate cancer where he combined external radiation with interstitial low dose and high dose brachytherapy. He established The Gulf International Cancer Center in Abu Dhabi in 2007 and was the first to utilize PET/CT scanning in radiation therapy treatment planning in the UAE.

Aly Abdel Razek, M.D., FACRO Executive Director Gulf International Cancer Center Chief of Radiation Oncology, UAE

Muhammad Ali Chaudhry, MD Medical Director, Tawam Molecular Imaging Center Clinical Assistant Professor of RadiologyJohns Hopkins University School of Medicine, UAE

Dr. Bhawna Sirohi joined Artemis Health Institute in July 2010 as Head of Medical and Haemato-Oncology. Prior to joining Artemis, she was Director of Medical Oncology at Max healthcare which she joined in Oct 2009. Dr. Sirohi has been associated with a world renowned premier institute- Royal Marsden Hospital, UK for more than a decade and previously with Tata Memorial hospital, Mumbai. She has a special interest in Breast and GI cancers & multiple myeloma. She hasbeen an international leader in research in cancer over a period of sixteen years. She is a leader in international societies, committees and is an innovator and senior figure of the UK and European initiative for irradiation protection.

She has delivered guest lectures worldwide and oral presentations at international forum. She hasmore than 300 publications in indexed journals and has 81 peer-reviewed clinical papersto her credit. She is on the editorial board of Indian Journal of Medical and Pediatric Oncology and Health Positive. She is the founder President of a charity NICCI (New India Cancer Charity Initiative) which will focus on complete cancer care from screening to diagnosis to treatment for patients in rural India.

Bhawna SirohiHead, Medical and Haemato OncologyArtemis Health Institute, India


Faculty Profile

Nagi S. El Saghir is Professor of Clinical Medicine at the American University of Beirut. He received his MD from the Free University of Brussels, Belgium (1978), completed his residency in Internal Medicine at the Brooklyn Hospital-Downstate, SUNY in New York (1981), and completed his fellowship in Hematology-Oncology at St. Lukes- Roosevelt Hospital Center-Columbia University in New York (1983). He is certified by the American Boards of Internal Medicine and Medical Oncology. Professor El Saghir has over 60 publications in peer-reviewed journals and is author of the book ABC of Breast Diseases from Prevention to Treatment, in Arabic and. In addition to Editorial Boards, he is Specialty Editor of The Breast and international editor of Journal of Clinical Oncology. He is Founding and Past-President of Lebanese Society of Medical Oncology and member of the Breast Health Global Initiative (BHGI), EORTC Breast Cancer Group, ESMO Developing Countries Task Force. He served as member of ASCO International Committee and ASCO Development and Education Award working group, ESMO National and Regional Representative Committees, He is recipient of Medal of Honor for Achievements from the President of Lebanon and the Cairo University Hospitals Medal of Acknowledgement for Contributions to Cancer Care in the Arab World, Lebanese Order of Physicians, and Lebanese Association of Womens rights, among others.

Nagi S. El SaghirProfessor of Clinical Medicine, Director, Breast Center of Excellence, NK Basile Cancer InstituteAmerican University of Beirut Medical Center, Lebanon

Vineet Gupta, MD Diplomate American Board (Int Medicine, Hematology, Med.Oncology) Group Medical DirectorHealth Care Global Enterprises Ltd, India

She is on the committee of David Adams Leukaemia Fund, UK and management committee ofCan Support, a charity dedicated to palliative care for cancer patients. She is patron for voiceof tobacco victims (VoTV).


Oncology with soul

Eisai MENA Regional Offi ceDubai Health Care City, AlRazi Building #64, Block B, Offi ce 1001P.O.Box 505182 Dubai - United Arab EmiratesTel.+9714 4471295 Fax +9714 4471299

Eisai A4 Ad.indd 1 10/09/2012 16:53


Faculty Profile

Muhammad Ali Chaudhry, MD Medical Director, Tawam Molecular Imaging Center Clinical Assistant Professor of RadiologyJohns Hopkins University School of Medicine, UAE

Nasser Al-Dhaibani, M.D., D.I.M., F.R.C.P.C, BRACHyRadiation Oncology DepartmentTawam Hospital, Al Ain, UAE

Cancer Imaging Session

Dorria Saleh El Sayed Salem Department of Radiology Cairo University, Egypt

Dr. Seema Kembhavi has been an Associate Professor and Consulting Radiologist at Tata Memorial Centre since 2005, after completing her training at the same centre. Her core interest lies in Breast and Paediatric Cancer Imaging. She has been a visiting fellow at St Jude Childrens ResearchHospital and the Memorial Sloan Kettering Cancer Centre in USA. She is a member of Indian Radiological and Imaging Association, Radiological Society of North America and International Society of Paediatric Oncology (SIOP). She has over 20 publications in indexed journals and has contributed several presentations and papers in breast and paediatric oncology at national/international conferences.

Seema Kembhavi Associate Professor, Department of RadiodiagnosisTata Memorial Centre, India


Faculty Profile

Atif Zaheer, MD is an assistant professor in the Department of Radiology at the Johns Hopkins UniversityDr. Zaheer attended medical school at the Aga Khan University. This was followed by a radiology residency at the Beth Israel Medical Center/Harvard Medical School in diagnostic radiology and a fellowship in abdominal imaging and intervention at the Brigham and Womens Hospital/Harvard Medical School. As faculty at the Johns Hopkins University, Dr. Zaheer is actively involved in research and education. He is currently the principal investigator on a large CT outcomes study identifying the underlying value of CT for common, widely accepted clinical indications in emergency department and primary care set-tings. He is also currently working on novel MRI techniques for diagnosing portal hypertension including the use of Magnetic resonance elastography. His other research interests include pancreatic and prostate imaging. Dr. Zaheer believes in a multidisciplinary approach for evaluation of disease and is actively involved in the multidisciplinary conferences for liver, pancreatitis and prostate. As an active member of the faculty he is a keen educator to the large residency and fellowship program as well as the in the departments latest initiative of e-learning which involves giving didactic lectures and case based conferences to residency programs within the United States and internationally to programs in South America and the Middle East. Dr. Zaheer is an active member of several societies including the Radiological Society of North America (RSNA) and Society of Abdominal Radiology. In addition,he serves as reviewer for CME activities for the American journal of Roentgenology.

Atif Zaheer Assistant Professor, Department of RadiologyJohns Hopkins University, USA

Mohei AbouziedUAE

Dr. Aly Abdel Razek is the Executive Director of The Gulf International Cancer Center and the Chief of Radiation Oncology. He graduated from Cairo University and completed his Radiation Therapy Residency at Washington University School of Medicine, St. Louis, Missouri where he joined the staff of Washington University. He contributed to four Radiation Oncology Textbooks and published many papers in the field. His area of interest is radiation therapy for prostate cancer where he combined external radiation with interstitial low dose and high dose brachytherapy. He established The Gulf International Cancer Center in Abu Dhabi in 2007 and was the first to utilize PET/CT scanning in radiation therapy treatment planning in the UAE.

Aly Abdel Razek, M.D., FACRO Executive Director Gulf International Cancer Center Chief of Radiation Oncology, UAE


Faculty Profile

Dr. Fleming is an Assistant Professor in the Department of Gynecologic Oncology atM.D. Anderson Cancer Center. Dr. Fleming returns to the Houston area after completing her residencytraining in Obstetrics and Gynecology at Duke University Medical Center and fellowship in Gynecologic Oncology at University of California at Los Angeles Medical Center. As a member of the M. D. Anderson Outreach Program, Dr. Fleming provides medical and surgical care to women with gynecologic malignancies in the greater Houston area. She has privileges at St. Lukes Episcopal Hospital, the Womans Hospital of Texas, Methodist Hospital, and Lyndon B. Johnson Hospital which enable patients to be seen in a private-practice office setting with access to the amenities and specialized services of M. D. Anderson Cancer Center including clinical trials. Dr. Fleming believes in workingclosely with the patient and the referring doctor in order to provide quality care through a comprehensive, multidisciplinary approach. Dr. Fleming has a special interest in minimally invasive surgery, including robotic-assisted laparoscopy, for appropriate patients with cervical, endometrial, and early-stage ovarian cancers. Minimally invasive surgery has revolutionized care for patients with gynecologic malignancies while improving patients quality of life postoperatively. In addition to providing excellent patient care, Dr. Fleming continues to pursue her research interests which include surgical innovation and outcomes in gynecologic malignancies, and personalizing treatment options for patients with ovarian and endometrial cancer.

She has authored and co-authored numerous articles in peer-reviewed journals on these and other subjects. In addition, she has been invited to write book chapters on a variety of topics in gynecologic oncology. Dr. Fleming is a member of the American College of Obstetricians and Gynecologists, the American Society of Clinical Oncology, Society of Gynecologic Oncologists, and American Association of Gynecologic Laparoscopists. In addition, she serves as reviewer for several journals includingGynecologic Oncology and Annals of Surgical Oncology.

Dr Sana Al-Sukhun is a Consultant in Medical Oncology and Hematology in private practice. She served as Director of Breast and Gynecology Service at King Hussein Cancer Centre. She is Assistant Professor of Medicine at the Department of Hematology/ Oncology in the Faculty ofMedicine at the University of Jordan. Dr Al-Sukhun is board certified from the American Board of Medical Oncology, American Board of Hematology and the American Board of Internal Medicine. She also has a Master of Science (Major in Cancer Biology). She is past president of the American Medical Graduate Society in Jordan; and an active member of various societies including the

Nicole D. Fleming Assistant ProfessorDepartment of Gynecologic OncologyUniversity of Texas MD Anderson Cancer Center, USA

Sana Al-SukhunDiplomat American Board of Internal Medicine/Medical Oncology & HematologyAssistant Professor of MedicineFaculty of Medicine, University of Jordan, Jordan

Gyne Oncology Session


Faculty Profile

Jordanian Medical Association, and the American Society of Clinical Oncology. Dr. Al-Sukhun is interested in breast & ovarian cancer, bone metastases, and translational research particularly development of targeted therapies. She authored and co-authored several scientific manuscripts in peer reviewed journals. Dr Al-Sukhun sits on several scientific committees and has been invited speaker to many national and regional conferences. She helped establish the National Breast Cancer Screening Guidelines Program in Jordan, chaired the first conference on Breast Cancer in Jordan in 2004, in addition to several local and regional conferences.

Shona Nag Jehangir Hospital, India

Luis M.Chiva, MD,PhD MD Anderson Cancer Center, SpainHead of Department of Gynecology OncologyAdjunct Professor of University of Texas, USA

Antonio Gonzlez graduated in medicine at University of Navarra in Pamplona (Spain), and subsequently trained in medical oncology at University Hospital Ramn y Cajal in Madrid (Spain) from 1994 to 1997. During part of 1997 he attended as an observer to The Mount Sinai School of Medicine in New York. He joined as staff member of the Medical Oncology Service at University Hospital Ramn y Cajal in 1998. From January 2009 he gained the position of Head of Medical Oncology Department at Centro Oncologico MD Anderson International Spain in Madrid, an affiliate institution of MD Anderson Cancer Centre in Houston. He specialises in the treatment of gynaecological and breast cancer and is the secretariat of the GEICO Group (Spanish group for investigation in ovarian cancer). He is also one of the GEICO representatives on the Gynecologic Cancer InterGroup, an international organisation for trials and treatment of gynaecological cancers. He is also a member of the board of the Spanish Society of Medical Oncology (SEOM).He has several publications to his name in the field of gynecological cancer, is Senior Editor of the journal Clinical and Translational Oncology, and Co-editor of the Spanish journal Revista de Ginecologa Oncolgica.

Francesco RaspagliesiFondazione IRCCSIstituto Nazionale dei Tumori, Italy

Antonio Gonzlez MartinChief of Medical Oncology DeptCentro Oncolgico MD Anderson International, Spain


Faculty Profile

Dr Luis Schiappacasse is a board certified Radiation Oncologist in four countries and was trained in France. He is a senior staff of the Academic Department of Radiotherapy, Centre Oscar Lambret, Lille, France. Regional referent (Nord - Pas-de-Calais region, France) for Radiation Oncology. He is a specialist in high-tech Radiotherapy (Tomotherapy, CyberKnife, more than 10 years experience in IMRT). He has a strong scientific and academic background, with studies in Methodology and ICH-GCP; lecturer / scientific programs in twelve countries. He was the scientific coordinator, 1st International Master in Advanced Technological Applications in Radiation Oncology, Spain.

Sudeep Gupta Professor of Medical OncologyTata Memorial Hospital, India

Luis SchiappacasseSenior Staff in Radiation OncologyAcademic Department of RadiotherapyCentre Oscar Lambret, France


Faculty Profile

Ravinder Deo India

Chirag ShahDirector, Dept. of Hematology, Oncology and Stem Cell Transplant,Apollo Hospitals International Ltd., India

Head and Neck Session

Somasundaram Subramanian, MD,Surgical Oncologist;Director, Eurasian Federation of Oncology &EAFO Educational & Research Center, Russia

Pankaj ChaturvediAssociate Professor Surgical Oncology, Head & Neck ServicesTata Memorial Hospital, Mumbai, India

Sangita BhandaryVice ChancellorPatan Academy of Health Sciences, Nepal


Faculty Profile

Dr Balazs B Lorincz works as the lead consultant oncologic and reconstructive head and neck surgeon at the Department of ENT, Head & Neck Surgery and Oncology of the University Medical Centre Hamburg-Eppendorf, Hubertus Wald Comprehensive Cancer Centre, Germany. His special focus of interest includes transoral and transaxillary robotic surgery, microvascular free flap reconstruction of head and neck defects as well as thyroid and parathyroid surgery. He became the first and is still the only TORS-proctor for Intuitive Surgical in Germany, as well as performed the first robotic thyroidectomy in this country. He has recently established an international head and neck fellowship academic training programme at the University of Hamburg, having just welcomed his first overseas fellow from McGill University, Montreal, Canada, for the following 18 months, to share his experience in head and neck oncology and reconstruction.

Dr Lorincz was appointed in his current position after having completed a 2-year head and neck clinical fellowship in Australia, having spent his first year in the Princess Alexandra Hospital in Brisbane, followed by a second year in the Sydney Head and Neck Cancer Institute at the Royal Prince Alfred Hospital in Sydney. During his time in Australia, he gained invaluable experience in the multidisciplinary management of head and neck cancer patients, including microvascular free flap reconstruction, thyroid surgery and robotic surgery. Prior to his fellowship, he completed his residency and registrar training at the University of Bergen, Norway and in the National Institute of Oncology, Budapest, Hungary,where he originally comes from. Dr Lorincz now lives in the hanseatic city of Hamburg with his physician wife and their two sons, currently expecting their third child to be born in 2013.

Balzs B. Lrincz M.D.ENT Consultant Head and Neck SurgeonHamburg-Eppendorf University Medical Centre, Germany

Dhairyasheel Savant Consultant Surgical OncologistReconstructive & Microvascular Surgeon, India

Arif JamshedConsultant Clinical OncologistShaukat Khanum Memorial Cancer Hospital and Research CentreIndia


Faculty Profile

Dr Ajit Venniyoor is currently serving as Senior Consultant in Medical Oncology at the National Oncology Centre in Royal Hospital in Muscat, Sultanate of Oman. He did his primary medical training in Armed Forces Medical College, Pune, India and served with distinction in the Indian Armed Forces from 1982 in various parts of India and abroad including Sri Lanka and Bhutan. He did his MD in Internal Medicine from the same college and DNB from National Board of Examination, New Delhi. He then did DM in Medical Oncology from Cancer Institute in Chennai, India and also trained in Stem Cell Transplant from Northwestern Memorial Hospital in Chicago. After serving in various oncology centres in Mumbai, Delhi and Lucknow, he took voluntary retirement from the service in 2010 and joined a private hospital in Mumbai, the 1500-bedded SevenHills Hospital, where he helped to set up the Oncology department. He then joined the present post in Jun 2011.

Dr Venniyoor has many articles to his credit in various Indian and international journals. His areas of interest included head and neck cancer and GI malignancies. He is a member of many societiesincluding ESMO and ICON. He has also been a teacher in the several hospitals that he worked in India.

Raghav Dwivedi UK

Ajit Venniyoor, MD, ECMO, DNB, DM Senior Consultant (Med Oncology)The Royal Hospital, Oman

Dr. Tanguy Seiwertis a specialist in head and neck cancer as well as lung cancer. Dr. Seiwert has a special interest in developing improved treatment strategies for these diseases. He looks for new ways to combine traditional treatments, such as chemotherapy and radiotherapy, with the latest targeted agents, in order to improve treatment results and decrease side effects. Dr. Seiwerts research focuses on the biology of head and neck cancer and lung cancer. In the laboratory, he studies targeted therapies that disrupt specific pathways vital to cancer growth and metastasis. He studies which novel drugs appear most promising, which individual tumors are more likely to respond to these treatments, and how to successfully combine therapies. Dr. Seiwert uses this pre-clinical knowledge to develop new treatments for use in clinical trials, and to ultimately improve patient care.

Tanguy y. Seiwert, MD Assistant Professor of MedicineThe University of Chicago Medicine, Chicago, USA


Faculty Profile

Dr. Woodson is professor and chair of otolaryngology at the Southern Illinois University School of Medicine and director of the SIU Voice Center at St. Johns Hospital. She completed two years of training in general surgery at Johns Hopkins Hospital, a residency in otolaryngology at Baylor College of Medicine, and a fellowship in laryngology in London. Dr. Woodson is a past president of the American Laryngological Society as well as the Society of University Otolaryngologists. She has served as examination chair on the American Board of Otolaryngology (ABO) and as chair of the Residency Review Committee for Otolaryngology. Other prior service includes the Board of Directors of the ABO, the Board of Directors of the American Academy of Otolaryngology, and the Council of the American Society for Head and Neck Surgery. She has received numerous awards, including Presidential Citations from the American Laryngological Society and the American Academy of Otolaryngology, and the Chevalier Jackson Award. She has been elected to the Johns Hopkins Society of Scholars. Dr. Woodson has authored or coauthored more than 100 scientific articles and book chapters and textbooks and has lectured extensively around the world. Her research in laryngeal physiology addresses treatment of the paralyzed larynx.

Cesare Piazza, MD is Assistant Professor of the Department of Otorhinolaryngology Head and Neck Surgery at the University of Brescia, Italy. He received his MD degree at the University of Pavia and he completed his residency programme in Otolaryngology in Brescia. His clinical and research activities are focused on head and neck oncology, with special emphasis to laryngeal, tracheal, oral and reconstructive surgery. Dr. Piazza is an active member of the European Laryngological Society since 2000 and is part of its Scientific Council since September 2010. He authored or co-authored 52 papers in peer-reviewed journals as well as 55 book chapters. He delivered 265 proffered papers and invited lectures in national and international Congresses and Courses.

Gayle Woodson, MD, FACSProfessor & Chair of OtolaryngologySouthern Illinois University School of MedicineDirector, SIU Voice Center, St. Johns Hospital, USA

Cesare Piazza, MDAssistant ProfessorDepartment of Otorhinolaryngology Head and Neck Surgery, University of Brescia, Italy

Gouri Pantvaidya MS, DNB, MRCS Associate Professor, Head and Neck SurgeryTata Memorial Hospital, Mumbai, India


Faculty Profile

Dr Shishir Shetty is a post graduate and super speciality guide and teacher. He was the first qualified surgical oncologist to be trained at Tata Memorial Hospital, India. He has special interest in trachea, lung, pancreas and liver surgeries. He trained in Emmory University, Atlanta, U.S.A and is currently the president of Cancure Foundation.

Dr Vedant Kabra graduated from Institute of Medical Sciences, Banaras Hindu University, India in 1995 with the University Gold Medal. He completed his masters in General Surgery from the same Institute in 1998 and was judged the Best Resident of the Institute. His thesis paper was awarded the Best Research Paper at the Annual conference of Association of Surgeons of India. Dr Kabra completed three year Senior Residency program at Tata Memorial Hospital, Mumbai and also didfellowships in Head & Neck Surgery and Breast surgery at the same hospital. Thereafter, he worked as Assistant Surgeon at Asian Institute of Oncology, Mumbai.

His presentations were awarded at various oncology conferences. Dr Kabra obtained membership of Royal Colege of Surgeons of Edinburgh in 2002. He also worked as a fellow and associate at National Cancer Centre of Singapore from Jan 2005 to Oct 2006. He has been a faculty at national and international conferences, has contributed 3 book chapters and several articles in peer-reviewed journals and is a member of several reputed Societies and Associations. Dr Kabra joined Max Healthcare in 2007 and is currently working as Senior Consultant Surgical Oncologist at Max Cancer Centre, Max healthcare, New Delhi.

Shishir Shetty, M.Ch (Surgical Oncology).M.SProfessor and Head Department of Surgical Oncology, Dr D.Y Patil Medical College, Hospital & Research Center, India

Vedant KabraSenior Consultant Surgical OncologistMax Cancer Centre, India

Hussain Abdulrahman, Msc (Cairo), FRCS Consultant & Head of ENT Department Dubai Hospital, UAE


Faculty Profile

Cyrus Kerawala graduated with an honours degree in medicine from St Georges Hospital, London and an honours degree in dentistry from the Royal London Hospital. During training he was awarded 17 undergraduate prizes. After experience in general surgery and neurosurgery he spent five years of specialist head and neck training in the North East of England. Cyrus passed the Intercollegiate Examination in Maxillofacial Surgery in September 1998 and has been on the Specialist Register of the General Medical Council since August 1999. He worked as a Consultant at the Royal Surrey County Hospital in Guildford and North Hampshire Hospital in Basingstoke for eight years before joining the Head and Neck Unit at the Royal Marsden Hospital in 2008.

Cyrus is the current Honorary Secretary of the British Association of Oral and Maxillofacial Surgeons and Associate Editor of the British Journal of Oral and Maxillofacial Surgery. He is also Chairman of the Education and Training Committee of the International Association of Oral Oncology and Chairman of the Norman Rowe International Education Foundation. Cyrus is author of a book on Maxillofacial Surgery and has written numerous chapters in other books. He has also authored over 60 peer-reviewed publications. He devotes a significant amount of time to teaching, professional training and continuing medical education. He has presented over 100 papers at international and national meetings and has been invited to lecture throughout Europe, America, the Middle East, Asia and Australia. In 2011 Cyrus carried out the first trans-oral robotic resection of a tumour in the UK. In the same year he was featured in The Times newspaper as one of Britains 50 top surgeons

Cyrus KerawalaHead & Neck Unit Royal Marsden Hospital, UK

Dr. Shashikant Juvekar MD is a Professor and Consultant Radiologist in the Department of Radiodiagnosis at Tata Memorial Centre. Dr Juvekar studied at Seth G S Medical College and King Edward VII Memorial Hospital in Mumbai, India; University of Bombay. This was followed by radiology training at King Edward VII Memorial Hospital Mumbai, India; University of Bombay.

Shaesta MehtaIndia

Shashikant Juvekar, MDProfessor and Consultant RadiologistDepartment of RadiodiagnosisTata Memorial Centre, India


Faculty Profile

Vishal Rao India

Chetna Bakshi India

His areas of interest are Head and Neck Radiology, Neuroradiology and Musculoskeletal Radiology. He is an ardent believer of multidisciplinary approach and is active member of Hospitals Disease Management Groups in Head and Neck, Neuro-oncology and Musculoskeletal Oncology.

He has been a visiting fellow at Withington Hospital, Manchester, UK:, MD Anderson Cancer Centre,Houston, Texas, USA and Stanford Medical Center, Stanford university, California, USA. He is a member of Indian Radiological and Imaging Association. He has several publications in indexed journals and has contributed presentations and papers at national and international conferences.He is Member of the Tata Memorial Centres Institutional Review Board and Radiation safety Committee. As faculty at Tata Memorial Centre he is actively involved in research and education.

Sankar Srinivasan, MD, MBBSSr Consultant, Medical OncologistApollo Specialty Hospital, India

Sandeep Goyle India


Faculty Profile

Ashish Bakshi India

Shailesh Bondarde India

Nirmal Raut India

Suraj PawarChairman & Managing DirectorKolhapur Cancer Centre, India

Kumar Alok PathakProfessor and Director of Surgical FellowshipUniversity of Manitoba, Canada


Faculty Profile

Dr Namrata Satyapal is currently serving as Senior Consultant in Radiation Oncology at the NationalOncology Centre in Royal Hospital in Muscat, Sultanate of Oman. She did her primary medical training from King Edward Memorial Hospital and Seth GS Medical College, Mumbai, India with distinction in Pharmacology. She went on to do Diploma in Medical Radiation Therapy from the esteemed Tata Memorial Hospital and Center, Mumbai and passed with Distinction and stood First in Mumbai University in 1997 followed by MD Radiotherapy from Tata Memorial Hospital and DNB (Radiotherapy) in May 1998 from National Board of Examination,

UAE Cancer Congress

Documents

Transcript of UAE Cancer Congress